NewsEvents

Your Yourlocation: Home > Clinical study of tiotropium bromide(136310-93-5) combined with salmeterol in the treatment of chronic obstructive pulmonary disease

To explore the clinical efficacy of tiotropium bromide(136310-93-5) combined with salmeterol in the treatment of chronic obstructive pulmonary disease. Studies have shown that chronic obstructive pulmonary disease by tiotropium combined with salmeterol treatment for patients can effectively enhance pulmonary function, the effect is accurate, worthy of promotion. The article published in 2015 08, "Chinese community physicians" magazine.

84 patients with chronic obstructive pulmonary disease were randomly divided into the observation group and the control group, 42 cases. The treatment group was treated with tiotropium bromide(136310-93-5) and salmeterol, and the control group was treated with tiotropium bromide(136310-93-5) alone.

The scores of FEV1, FVC and FEV1 / FVC, FEV1 in the observation group were significantly higher than those in the control group (P <0.05). The ADL score of the observation group was 5.12 ± 0.15, significantly higher than that of the control group The walking distance of the observation group was 357.4 ± 29.5 m, which was significantly higher than that of the control group, the difference was statistically significant (P <0.05).

Address: TEL:0531-82375879 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved